Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.8 GBX | -0.76% | +3.72% | -7.14% |
26/03 | Scancell doses first patient in melanoma-focused trials | AN |
22/03 | Seneca Growth Capital announces tepid 2023 results | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.14% | 10Cr | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+45.09% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- SCLP Stock
- News Scancell Holdings plc
- Earnings Flash (SCLP.L) SCANCELL HOLDINGS Reports FY23 Revenue GBP5.3M